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The network of HIV counseling and testing centers in São Paulo, Brazil is a major source of data used to build
epidemiological profiles of the client population. We examined HIV-1 incidence from November 2000 to April 2001,
comparing epidemiological and socio-behavioral data of recently-infected individuals with those with long-standing
infection. A less sensitive ELISA was employed to identify recent infection. The overall incidence of HIV-1 infection
was 0.53/100/year (95% CI: 0.31-0.85/100/year): 0.77/100/year for males (95% CI: 0.42-1.27/100/year) and 0.22/100/
year (95% CI: 0.05-0.59/100/year) for females. Overall HIV-1 prevalence was 3.2% (95% CI: 2.8-3.7%), being 4.0%
among males (95% CI: 3.3-4.7%) and 2.1% among females (95% CI: 1.6-2.8%). Recent infections accounted for 15%
of the total (95% CI: 10.2-20.8%). Recent infection correlated with being younger and male (p = 0.019). Therefore,
recent infection was more common among younger males and older females.
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In December 2001, 51,841 AIDS cases were reported in the
city of São Paulo, corresponding to 22% of all AIDS cases
reported in Brazil as a whole (http://www.aids.gov.br). The
HIV-1 epidemic in Brazil is characterized by the number of
reported AIDS cases and the number of HIV-infected pregnant
women (and their infected children), as well as HIV-1 sentinel
surveillance of certain population groups. In several studies,
recent HIV-1 infection has been described using a less
sensitive ELISA [1-4]. This detection strategy, known as the
serologic testing algorithm for recent HIV seroconversion
(STARHS) [3], has been used to estimate HIV-1 incidence and
to investigate epidemiological aspects in newly-infected
individuals.
The city of São Paulo, where nearly 25% of all Brazilian
AIDS cases occur, is recognized as the epicenter of the AIDS
epidemic in Brazil (http://www.aids.gov.br). The São Paulo
Municipal STD/HIV Network comprises 22 outpatient clinics
located throughout the city. One important element of this
network is the service provided by HIV counseling and testing
(HIV CT) centers, which conduct STD/HIV testing and provide
prevention counseling. The health care system is also an
important source of data, enabling studies of HIV-1 prevalence
and epidemiological profiles of client populations.
In the STARHS methodology, serum samples testing
positive for HIV-1 in the initial ELISA are retested. In the
second test, a less sensitive ELISA is performed. The less
sensitive ELISA protocol uses higher serum dilutions and
shorter incubation periods. If a sample tests positive in the
conventional ELISA and negative in the less sensitive ELISA,
the viral infection is presumed to have occurred within the
preceding 170 days, and the patient is classified as having
been recently infected with HIV-1. This system allows the
incidence of recent infection to be estimated.
We used the STARHS methodology to calculate the
number of recent HIV-1 infections in samples collected at HIV
CT centers between November 2000 and April 2001. We also
studied the epidemiological and socio-behavioral aspects of
HIV-positive individuals that had been recently infected, as
well as those of individuals presenting long-standing infection.
Material and Methods
Study Design
This was a cross-sectional study using information
gathered from questionnaires administered between
November 2000 and April 2001 during routine HIV CT center
visits before and after testing. Five HIV CT centers were
involved in this study and are identified by their locations:
Henfil, Lapa, Pirituba, Santo Amaro, and São Miguel.
STARHS
Patient blood samples were collected in vacutainer tubes
(Becton-Dickinson, Rutherford, NJ, USA). On the same day,
samples were transferred to one of the three public reference
laboratories for storage. All samples were tested twice, using
conventional HIV-1 ELISA. Double-negative samples were
considered HIV-1 negative. Samples for which the ELISA results
were inconclusive, as well as those testing positive for HIV-1
only once, were further analyzed by Western blot according to
the guidelines established by the Brazilian Health Ministry [3].
Samples classified as HIV-1 positive were sent to the
Retrovirology Laboratory of the Federal University of São
Paulo to be analyzed using STARHS. The Vironostika HIV-1
Micro-ELISA System kit was used (LS HIV-1 EIA; Organon
Teknika, Durham, NC, USA), according to the manufacturer’s
instructions.
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Serum samples were diluted to 1:20,000, and incubation
times were modified. Vironostika negative controls, Centers
for Disease Control and Prevention calibrators, high-positive
controls, and low-positive controls were also diluted and
incubated according to the manufacturer’s instructions.
Sample selection and control analysis were performed in
triplicate. Sample optical density (SOD) was calculated using
the equation:
Samples in which the SOD screening value was below 2.0
were tested in triplicate as a confirmatory measure. The SOD
was calculated based on median OD values measured in
triplicate. Samples in which the confirmed SOD value was
below 1.0 were determined to have originated from patients
having acquired the HIV-1 infection within the preceding 170
days [3].
Statistical Analysis
In our analysis, the outcome variable was the timing of
HIV-1 infection (recent or not). Explanatory and control
variables included ethnicity, education, marital status, type of
exposure, and use of condoms. The annual HIV-1 incidence,
expressed as the percentage of new cases/year that were
identified as cases of recent infection, was calculated for the
population as a whole and by gender using the estimator
included in the Vironostika-LS protocol:
*Study period = 182.5 days.
The prevalence of HIV-1 infection was calculated as the
ratio between the number of HIV-1-positive individuals and
the number of individuals tested in the first sample. The 95%
confidence intervals (95% CIs) were calculated for incidence
and prevalence of recent HIV-1 infections. These 95% CIs
were used for estimation and to compare prevalence and
incidence by gender. Correlations between the outcome and
explanatory variables were identified using the chi-square test
or Fisher’s exact test, together with linear trend tests. The Epi
Info, version 6.0 [5], and Stata, version 7.0 (Stata, College
Station, TX, USA) programs were used to construct and
analyze the database.
The Ethics in Research Committee of the Training and
Reference Center for STD/AIDS (São Paulo State Health
Secretariat) approved the study, and all participants gave
written informed consent.
Results
Six thousand individuals (3,486 males and 2,514 females)
were tested, of which 194 (140 males and 54 females) were
found to be HIV-1 positive and were included in our study
sample. Among those 194, 105 had been tested at Henfil, 10 at
Lapa, 9 at Pirituba, 23 at Santo Amaro, and 31 at São Miguel.
The overall prevalence of HIV-1 infection was 3.2% (95% CI:
2.8–3.7%). Prevalence varied by gender, being 4.0% among
males (95% CI: 3.3–4.7%) and 2.1% among females (95% CI:
1.6–2.8%). Among the individuals identified as HIV-1 positive,
15% were classified as having been recently infected (95% CI:
10.2–20.8%). The overall incidence of recent HIV-1 infection,
regardless of gender, was 0.53/100/year (95% CI: 0.31–0.85/
100/year), being 0.77/100/year for males (95% CI: 0.42–1.27/
100/year) and 0.22/100/year for females (95% CI: 0.05-0.59/
100/year). Cases of recent infection tended to occur more
frequently in individuals under 29 years of age (p = 0.043: 19/
29; 65.5% versus 67/165; 40.6%). This tendency was stronger
for men under 29 years of age (p = 0.019 for men:18/24; 62.9%
versus women: 1/5; 5.6% - data not shown). The patterns of
age distribution among recently infected individuals differed
by gender (Figure 1). The incidence among males increased
significantly by 20 years of age, peaking at 25 and dropping
markedly thereafter. Among women, there was a trend towards
increased incidence after 25 years of age, peaking at 35 and
decreasing thereafter. t Recent HIV-1 infection (Table 1) did
not correlate significantly with ethnicity (p = 0.702), education
(p = 0.555), marital status (p = 0.178), employment status (p =
0.810), income (p = 0.549), use of condoms (p = 0.480), type of
exposure (p = 0.314), or number of partners (p = 0.851).
Discussion
We examined the incidence of HIV-1 among individuals
seeking counseling or treatment at the HIV CT centers of the
STD/AIDS network in the city of São Paulo. Rates of recent
infection were estimated using the STARHS methodology,
which has been successfully employed for this purpose in
various studies [2,6-9].
The HIV-1 prevalence that we observed (3.2%) was lower
than the 4.4% reported among HIV CT center users in a
previous study conducted in the city of São Paulo[10] and
the 7.1% found among such clients in the city of Santos, also
located in the state of São Paulo[11]. However, it was higher
than the 2.1% observed in the city of San Francisco, California
(USA) [2].
Similar numbers of men and women were tested at the HIV
CT centers. However, HIV-1 infections were more prevalent
among men, likely reflecting historical aspects of the local
epidemic in terms of demographics and exposure. Alves et al.
found the same to be true for HIV CT center users in the city
of Santos [11]. We found that the incidence of recent HIV-1
infection was similar for men and women, which is also in
agreement with the findings of Alves et al. [11] In view of the
trend towards a decrease in the male-to-female ratio of AIDS
cases in Brazil, which dropped from 23:1 in the mid-1980s to
1.5:1 in 2005 (www.prefeitura.sp.gov.br/dstaids), these findings
were expected.
The incidence of recent HIV-1 infection observed in our
study (0.53/100/year) was lower than that described in
Estimating HIV-1 Incidence in Brazil
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previous studies involving diverse population groups (men
who have sex with men, injectable drug users, and others)
and analysis of stored serum samples. Studies conducted in
Brazil have reported incidence rates varying from 1.2 to 2.8/
100/year [10,11].
In our study, 60% of the individuals tested were men who
have sex with men. Nevertheless, we found no significant
difference between men who have sex with men and
heterosexual men in terms of recent infection (p = 0.314; Table
1). This might indicate either similarity between the two
exposure groups or low statistical power to detect differences
(related to the small sample size). A sound estimate of HIV-1
incidence and the epidemiological aspects of newly-infected
populations will only be possible when larger numbers of
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Table 1. Distribution of individuals by socio-demographic and HIV-1 serological status. Data compiled from November 2000 to
April of 2001 from four counseling and testing centers of the São Paulo Municipal Health Network System.
Characteristic Recent infection
Yes No p
N % N %
Gender
Male 24 17.1 116 82.9 0.168*
Female 5 9.3 49 90.7
Age (years)
< 20 3 33.3 6 66.7 0.043†
20–29 16 20.8 61 79.2
30–39 5 7.6 61 92.4
> 40 5 11.9 37 88.1
Ethnicity
White 16 15.5 87 84.5 0.702†
Black 4 21.1 15 79.0
Mixed 8 18.2 36 81.8
Asian 0 - 7 100.0
Education
None 12 15.6 65 84.4 0.555†
Elementary School 7 15.2 39 84.8
High School 9 17.7 42 82.4
University Degree 0 - 12 100.0
Marital Status
Single 21 18.9 90 81.1 0.178*
Married 7 11.1 56 88.9
Employment Status
Employed 22 14.6 129 85.4 0.810*
Unemployed 7 16.3 36 83.7
Income‡
0 3 11.5 31 20.7 0.549†
1–2 3 11.5 27 18.0
3–4 13 50.0 62 41.3
5–6 7 26.9 30 20.0
Exposure Category
Heterosexual 11 12.5 77 87.5 0.314*
Homosexual 10 22.2 35 77.8
Bisexual 7 18.0 32 82.1
Use of Condoms
Always 6 11.5 46 88.5 0.480†
Sporadic 17 19.5 70 80.5
Never 5 14.7 29 85.3
 Number of Partners
Single 8 17.0 39 83.0 0.851*
Multiple 19 15.8 101 84.2
*Pearson’s chi-square test. †Fisher’s exact test. ‡Expressed as the number of times the local minimum wage.
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recently-infected individuals are identified using STARHS.
We noted that a significant correlation between recent
infection and age was observed only for males that were
bisexual; among 39 bisexual males 100% (7/7) presented recent
infection versus 28% of the individuals with long standing
infection (9/32, p = 0.003). This group seems to be at greater
risk of acquiring HIV-1 infection in this region of Brazil; similar
findings have been reported for young gay men in other areas
of the world [12]. However, among women living in this region,
the risk of recent HIV-1 infection seems to peak at a later age
(Figure 1). Further prospective studies should be conducted
in order to confirm these differences and seek to explain them.
In addition, molecular epidemiological studies characterizing
cases of recent HIV-1 infection will certainly lead to a better
understanding of HIV-1 epidemics and their trends in terms of
the profile of the virus and primary resistance to antiretroviral
drugs. We recognize the fact that the retrospective nature of
this study, as well as the small number of individuals analyzed,
might have limited our evaluation of epidemiological aspects.
However, as previously mentioned, preliminary analyses
generated here could provide insight for the design of future
studies. We also understand that analysis of demographic
and behavioral data from HIV-seronegative individuals seeking
testing in the Counseling and Testing Centers would provide
more insight into the nature of HIV epidemics in Brazil;
unfortunately, these data were not available to us.
Identifying cases of recent HIV-1 infection has clinical
implications, allowing the implementation of early intervention
measures, which could result in better control of virus
replication and propagation during primary infection. This
strategy might also help define the inclusion criteria for
therapeutic and pathogenesis studies. In addition, since it
also identifies populations at greater risk for HIV-1 infection,
profiling the recently infected could be considered a
prevention tactic. Furthermore, the inclusion of HIV-1
seronegative individuals in studies focusing on recent
infections may help us understand other components of this
epidemic and thereby lead to the development of better
intervention measures.
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Figure 1. Distribution of HIV-1 patients by gender and age.
Data compiled from November 2000 to April 2001 from four
counseling and testing centers within the São Paulo Municipal
Health Network System.
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